22 Cathie Wood Intellia Therapeutics Trades
Cathie Wood acquired 9.66 Million Intellia Therapeutics shares worth $445 Million. That's 3.05% of their equity portfolio (11th largest holding). The investor owns 12.36% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares seventeen more times and sold shares on four occasions. The stake costed the investor $339 Million, netting the investor a gain of 31% so far.
Avg closing price
Price range
Increased shares by 1.5% (+142 Thousand shares)
Q3 2022
Avg closing price
$62.04
Price range
$53.92
-
$71.70
Increased shares by 5.9% (+534 Thousand shares)
Q2 2022
Avg closing price
$50.78
Price range
$38.49
-
$76.21
Increased shares by 13.4% (+1.06 Million shares)
Q1 2022
Avg closing price
$84.72
Price range
$58.27
-
$118.99
Increased shares by 17.4% (+1.17 Million shares)
Q4 2021
Avg closing price
$125.27
Price range
$100.76
-
$138.36
Sold 12.2% shares (-941 Thousand shares)
Q3 2021
Avg closing price
$151.40
Price range
$132.37
-
$176.78
Sold 20.1% shares (-1.93 Million shares)
Q2 2021
Avg closing price
$77.87
Price range
$60.88
-
$161.91
Sold 14.1% shares (-1.58 Million shares)
Q1 2021
Avg closing price
$67.12
Price range
$46.59
-
$83.68
Sold 1.9% shares (-213 Thousand shares)
Q4 2020
Avg closing price
$36.31
Price range
$18.83
-
$63.53
Increased shares by 0.0% (+1.37 Thousand shares)
Q3 2020
Avg closing price
$20.85
Price range
$17.47
-
$24.93
Increased shares by 11.4% (+1.16 Million shares)
Q2 2020
Avg closing price
$16.99
Price range
$11.14
-
$22.87
Increased shares by 17.1% (+1.5 Million shares)
Q1 2020
Avg closing price
$13.47
Price range
$9.44
-
$15.58
Increased shares by 9.5% (+760 Thousand shares)
Q4 2019
Avg closing price
$13.91
Price range
$10.43
-
$17.67
Increased shares by 17.3% (+1.18 Million shares)
Q1 2019
Avg closing price
$14.91
Price range
$12.79
-
$17.62
Increased shares by 18.2% (+1.05 Million shares)
Q4 2018
Avg closing price
$18.59
Price range
$11.39
-
$27.13
Increased shares by 27.5% (+1.24 Million shares)
Q3 2018
Avg closing price
$29.09
Price range
$25.78
-
$32.60
Increased shares by 25.3% (+911 Thousand shares)
Q2 2018
Avg closing price
$24.23
Price range
$20.02
-
$30.79
Increased shares by 162.0% (+2.23 Million shares)
Q1 2018
Avg closing price
$24.59
Price range
$19.43
-
$34.95
Increased shares by 269.2% (+1 Million shares)
Q4 2017
Avg closing price
$23.09
Price range
$17.39
-
$31.12
Increased shares by 113.1% (+198 Thousand shares)
Q3 2017
Avg closing price
$18.84
Price range
$15.16
-
$25.75
Increased shares by 118.9% (+95 Thousand shares)
Q2 2017
Avg closing price
$13.97
Price range
$11.38
-
$17.02
